BioVaxys Technology Corp. (BIOV.CN)
CAD 0.06
(0.0%)
CAD 0.06
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -7.68 Million CAD | -247.63% |
| 2022 | - CAD | 155.77% |
| 2021 | - CAD | -486.69% |
| 2020 | - CAD | -376.29% |
| 2019 | - CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -370.7 Thousand CAD | 99.35% |
| 2024 Q3 | -1.18 Million CAD | 0.0% |
| 2024 Q2 | -539.19 Thousand CAD | 100.0% |
| 2023 Q2 | 97.97 Thousand CAD | 111.25% |
| 2023 Q1 | -871.04 Thousand CAD | -113.0% |
| 2023 FY | - CAD | -280.28% |
| 2023 Q4 | -4.19 Million CAD | -1022.91% |
| 2023 Q3 | 454.33 Thousand CAD | 363.75% |
| 2022 Q1 | -1.2 Million CAD | 52.03% |
| 2022 Q4 | 6.7 Million CAD | 842.36% |
| 2022 FY | - CAD | 155.77% |
| 2022 Q3 | -902.89 Thousand CAD | 11.38% |
| 2022 Q2 | -1.01 Million CAD | 15.19% |
| 2021 Q4 | -2.5 Million CAD | -184.12% |
| 2021 FY | - CAD | -486.69% |
| 2021 Q1 | -1.53 Million CAD | -79.81% |
| 2021 Q3 | -881.41 Thousand CAD | 41.05% |
| 2021 Q2 | -1.49 Million CAD | 2.77% |
| 2020 Q2 | -65.4 Thousand CAD | -94.62% |
| 2020 Q1 | -33.6 Thousand CAD | 50.49% |
| 2020 FY | - CAD | -376.29% |
| 2020 Q4 | -855.19 Thousand CAD | -511.7% |
| 2020 Q3 | -139.8 Thousand CAD | -113.75% |
| 2019 Q3 | -37.8 Thousand CAD | 35.45% |
| 2019 Q1 | -65.44 Thousand CAD | 49.77% |
| 2019 Q4 | -67.88 Thousand CAD | -79.55% |
| 2019 Q2 | -58.56 Thousand CAD | 10.51% |
| 2019 FY | - CAD | 0.0% |
| 2018 Q4 | -130.28 Thousand CAD | -321.14% |
| 2018 Q3 | -30.93 Thousand CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -4.98 Million CAD | -54.318% |
| Asep Medical Holdings Inc | -8.13 Million CAD | 5.515% |
| BetterLife Pharma Inc. | -3.19 Million CAD | -140.872% |
| ChitogenX Inc. | -2.69 Million CAD | -185.349% |
| Rapid Dose Therapeutics Corp. | -3.02 Million CAD | -154.148% |
| Defence Therapeutics Inc. | -12.67 Million CAD | 39.354% |
| Entheon Biomedical Corp. | 13.99 Thousand CAD | 55036.84% |
| Gemina Laboratories Ltd. | -5.17 Million CAD | -48.524% |
| Glow Lifetech Corp. | -1.26 Million CAD | -508.635% |
| Lexston Life Sciences Corp. | -648.32 Thousand CAD | -1085.721% |
| Pharmala Biotech Holdings Inc. | -710.18 Thousand CAD | -982.438% |
| Doseology Sciences Inc. | -319.47 Thousand CAD | -2306.21% |
| MYND Life Sciences Inc. | -1.82 Million CAD | -321.177% |
| Nova Mentis Life Science Corp. | -1.2 Million CAD | -539.384% |
| PharmaTher Holdings Ltd. | -3.04 Million CAD | -152.592% |
| PreveCeutical Medical Inc. | -955.08 Thousand CAD | -704.88% |
| Telescope Innovations Corp. | -5.49 Million CAD | -40.013% |